BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/8/2022 9:04:30 AM | Browse: 677 | Download: 2482
 |
Received |
|
2022-07-20 14:18 |
|
Peer-Review Started |
|
2022-07-20 14:21 |
|
First Decision by Editorial Office Director |
|
2022-10-22 03:06 |
|
Return for Revision |
|
2022-10-22 03:06 |
|
Revised |
|
2022-11-04 04:35 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-11-22 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-11-23 02:31 |
|
Articles in Press |
|
2022-11-23 02:31 |
|
Edit the Manuscript by Language Editor |
|
2022-11-21 00:51 |
|
Typeset the Manuscript |
|
2022-12-01 09:35 |
|
Publish the Manuscript Online |
|
2022-12-08 09:04 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
3,6-dichlorobenzo[b]thiophene-2-carboxylic acid alleviates ulcerative colitis by suppressing mammalian target of rapamycin complex 1 activation and regulating intestinal microbiota
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qiong-Zi He, Peng Wei, Jun-Zhi Zhang, Tong-Tong Liu, Kun-Qun Shi, Huan-Huan Liu, Jing-Wei Zhang and Shi-Jia Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82074241 |
| Project of Jiangsu Province Hospital of Traditional Chinese Medicine Peak Talent |
y2021rc36 |
|
| Corresponding Author |
Shi-Jia Liu, PhD, Research Fellow, Department of Medicine, First Affiliated Hospital, Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Qinhuai District, Nanjing 210000, Jiangsu Province, China. liushijia2011@163.com |
| Key Words |
3,6-dichlorobenzo[b]thiophene-2-carboxylic acid; Ulcerative colitis; Mechanistic target of rapamycin complex 1; Intestinal flora; Dextran sodium sulfate; Cyclooxygenase-2 |
| Core Tip |
Gut microbiota dysbiosis and hyperactivated mammalian target of rapamycin complex 1 (mTORC1) make great contributions to the pathogenesis of ulcerative colitis (UC). In our study, 3,6-dichlorobenzo[b]thiophene-2-carboxylic acid (BT2) exerted significant therapeutic effects on the amelioration of dextran sodium sulfate-induced acute colitis. Our work reported that BT2 played an anti-UC role through suppression of branched amino acid-associated mTORC1 activation and modulation of the intestinal flora. Overall, BT2 could represent a potential candidate drug in the design of treatment strategies for UC. |
| Publish Date |
2022-12-08 09:04 |
| Citation |
He QZ, Wei P, Zhang JZ, Liu TT, Shi KQ, Liu HH, Zhang JW, Liu SJ. 3,6-dichlorobenzo[b]thiophene-2-carboxylic acid alleviates ulcerative colitis by suppressing mammalian target of rapamycin complex 1 activation and regulating intestinal microbiota. World J Gastroenterol 2022; 28(46): 6522-6536 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i46/6522.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i46.6522 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
